US Business Exploration of Immortality-as-a-Service (July 2024)

In July 2024, INTO Global Business Communications led a high-level business delegation to the San Francisco Bay Area, centered on the Longevity sector. The delegation comprised executives and investors from prominent Medtech companies like Alibaba Health, iKang Healthcare, and WonderLab, alongside leading investment firms such as Greenwoods Asset Management, Chang’an Capital, and Tactex Asset Management. The visit facilitated in-depth discussions with key players in the life science and AI medical fields, including Altos Labs, Retro Biosciences, OneSkin, Turn Bio, Rubedo Life Sciences, Juvena Therapeutics, and esteemed scientific figures, including Dr. Sebastiano from Stanford's Cancer Research Institute and Nobel Prize winner Dr. Schekman of UC Berkeley.

Met with Rubedo Life Sciences' Co-founder & CEO
Met with Turn Bio's CEO
Met with OneSkin' Founder & CEO
Met with Deciduous Therapeuticso's Founder & CEO
Met with Cyclarity Therapeutics' Founder & CEO
Met with NaNotics ' CEO
Met with Altos Labs' Scientist
Met with Juvena Therapeutics' Co-founder & CEO
Met with Stanford School of Medicine's Director
3f9db43951c54ba79f949fc1f89cb672~tplv-obj.jpgMet with Nobel Prize winner in Physiology or Medicine at UC Berkeley